Figure 2.
Immunogenicity of recombinant Adjuvanted Recombinant Zoster Vaccine (RZV) at different follow-up times stratified between treatment groups and compared with healthy controls (HCs).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.